Consistent with the literature [17,18,19], our analysis revealed an opposite trend in the expression levels of MCL1 and BCL-XL compared to BCL2, with a reduction in both BCL2 family members in GATA2-EB patients, although not reaching statistical significance (Figure 5A–C). The gene discussed is MCL1; the disease is epidermolysis bullosa.